Hung MC - Search Results

1

A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

Xie X, Hsu JL, Choi MG, Xia W, Yamaguchi H, Chen CT, Trinh BQ, Lu Z, Ueno NT, Wolf JK, Bast RC Jr, Hung MC. Xie X, et al. Among authors: hung mc. Mol Cancer Ther. 2009 Aug;8(8):2375-82. doi: 10.1158/1535-7163.MCT-09-0056. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671744 Free PMC article.

2

Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.

Yu DH, Scorsone K, Hung MC. Yu DH, et al. Among authors: hung mc. Mol Cell Biol. 1991 Mar;11(3):1745-50. doi: 10.1128/mcb.11.3.1745-1750.1991. Mol Cell Biol. 1991. PMID: 1671710 Free PMC article.

3

Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products.

Yu D, Suen TC, Yan DH, Chang LS, Hung MC. Yu D, et al. Among authors: hung mc. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4499-503. doi: 10.1073/pnas.87.12.4499. Proc Natl Acad Sci U S A. 1990. PMID: 1972274 Free PMC article.

4

Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.

Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC. Yu D, et al. Among authors: hung mc. Oncogene. 1995 Oct 5;11(7):1383-8. Oncogene. 1995. PMID: 7478560

5

HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model.

Zhang Y, Yu D, Xia W, Hung MC. Zhang Y, et al. Among authors: hung mc. Oncogene. 1995 May 18;10(10):1947-54. Oncogene. 1995. PMID: 7761095

6

Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.

Yu D, Shi D, Scanlon M, Hung MC. Yu D, et al. Among authors: hung mc. Cancer Res. 1993 Dec 1;53(23):5784-90. Cancer Res. 1993. PMID: 7902209

7

Negative regulation of the neu promoter by the SV40 large T antigen.

Matin A, Hung MC. Matin A, et al. Among authors: hung mc. Cell Growth Differ. 1993 Dec;4(12):1051-6. Cell Growth Differ. 1993. PMID: 7906953

8

Transcriptional regulation of neu by RB and E1A in rat-1 cells.

Yu D, Matin A, Hinds PW, Hung MC. Yu D, et al. Among authors: hung mc. Cell Growth Differ. 1994 Apr;5(4):431-8. Cell Growth Differ. 1994. PMID: 8043517

9

Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.

Yu D, Wolf JK, Scanlon M, Price JE, Hung MC. Yu D, et al. Among authors: hung mc. Cancer Res. 1993 Feb 15;53(4):891-8. Cancer Res. 1993. PMID: 8094034

10

Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer.

Xing X, Matin A, Yu D, Xia W, Sorgi F, Huang L, Hung MC. Xing X, et al. Among authors: hung mc. Cancer Gene Ther. 1996 May-Jun;3(3):168-74. Cancer Gene Ther. 1996. PMID: 8725881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

917 results

Search Page

Filters